Skip to main content

Edris Badreddin's Form 4 filing

SpringWorks Therapeutics, Inc.SWTX · filed Mar 5, 2025

Accession no.
0001104659-25-021008
Filed
Mar 5, 2025
Trade date
Mar 3, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $1.08M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edris BadreddinCIK 0001786966Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockSSaleDisposed−3,924$53.12F2−$208,442.88185,788Direct
Mar 3, 2025Common StockSSaleDisposed−12,078$54.26F3−$655,352.28173,710Direct
Mar 3, 2025Common StockSSaleDisposed−3,598$55.12F4−$198,321.76170,112Direct
Mar 3, 2025Common StockSSaleDisposed−400$56.20F5−$22,480169,712Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.725 to $53.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.73 to $54.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.74 to $55.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.90 to $56.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)